An integrated approach to the discovery of potent agelastatin A analogues for brain tumors: chemical synthesis and biological, physicochemical and CNS pharmacokinetic analyses
[EN] TREATING BRAIN CANCER USING AGELASTATIN A (AA) AND ANALOGUES THEREOF<br/>[FR] TRAITEMENT DU CANCER DU CERVEAU À L'AIDE D'AGÉLASTATINE A (AA) ET D'ANALOGUES DE CELLE-CI
申请人:MAYO FOUNDATION
公开号:WO2014059314A1
公开(公告)日:2014-04-17
This document relates to compounds and compositions useful for treating cancers, such as brain and nervous system cancers.
这份文件涉及用于治疗癌症的化合物和组合物,如脑部和神经系统癌症。
Treating Brain Cancer using Agelastatin A (AA) and Analogues Thereof
申请人:MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
公开号:US20150274742A1
公开(公告)日:2015-10-01
This document relates to compounds and compositions useful for treating cancers, such as brain and nervous system cancers.
这份文件涉及到对治疗癌症,如脑和神经系统癌症有用的化合物和组合物。
US9464093B2
申请人:——
公开号:US9464093B2
公开(公告)日:2016-10-11
An integrated approach to the discovery of potent agelastatin A analogues for brain tumors: chemical synthesis and biological, physicochemical and CNS pharmacokinetic analyses
作者:Zhimin Li、Daisuke Shigeoka、Thomas R. Caulfield、Takashi Kawachi、Yushi Qiu、Takuma Kamon、Masayoshi Arai、Han W. Tun、Takehiko Yoshimitsu
DOI:10.1039/c3md00094j
日期:——
(−)-Agelastatin A (AA), isolated from the coral sea axinellid sponge Agelas dendromorpha, has shown a high antineoplastic activity. We have synthesized eighteen AA analogues and analyzed their cytotoxicities towards three cancer cell lines. By the structure–activity relationship (SAR) study, we identified three novel analogues with higher or comparable cytotoxic activities to AA. They were subjected to chemoinformatic analysis, which revealed physicochemical properties favoring excellent central nervous system (CNS) penetration. CNS pharmacokinetic analysis in murine models validated the chemoinformatic prediction and revealed that these analogues indeed had better CNS penetration than AA. These novel potent AA analogues deserve further evaluation for therapeutic use against cancers, particularly primary and secondary brain tumors.